Long-Chain and Very Long-Chain Ceramides Mediate Doxorubicin-Induced Toxicity and Fibrosis
Doxorubicin (Dox) is a chemotherapeutic agent with cardiotoxicity associated with profibrotic effects. Dox increases ceramide levels with pro-inflammatory effects, cell death, and fibrosis. The purpose of our study was to identify the underlying ceramide signaling pathways. We aimed to characterize...
Saved in:
Main Authors: | Tom Kretzschmar, Mohamed M. Bekhite, Jasmine M. F. Wu, Daniela Haase, Martin Förster, Tina Müller, Sandor Nietzsche, Martin Westermann, Marcus Franz, Markus H. Gräler, P. Christian Schulze |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/6c46b5dcf5a94933a40b90adf86c3617 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Periplocymarin Alleviates Doxorubicin-Induced Heart Failure and Excessive Accumulation of Ceramides
by: Weijing Yun, et al.
Published: (2021) -
Plasma Ceramides Pathophysiology, Measurements, Challenges, and Opportunities
by: Melania Gaggini, et al.
Published: (2021) -
Ceramide Remodeling and Risk of Cardiovascular Events and Mortality
by: Linda R. Peterson, et al.
Published: (2018) -
Ceramides: Shared Lipid Biomarkers of Cardiovascular Disease and Schizophrenia
by: Anna I. Tkachev, et al.
Published: (2021) -
Involvement of Ceramides in Non-Alcoholic Fatty Liver Disease (NAFLD) Atherosclerosis (ATS) Development: Mechanisms and Therapeutic Targets
by: Daniela Maria Tanase, et al.
Published: (2021)